Biologics Drug Product: Strategies For Formulation, Tech Transfer And Delivery System

Source: Catalent

The industry continues to see rapid growth within biologics, bringing new and improved medicines to patients. As these biologics progress through the clinic and into the market it’s important to understand your products’ characteristics and formulation aiding in successful technology transfers and lifecycle management transitions into new presentations.

This webinar covers the key considerations for formulation screening of therapeutic proteins with a focus on maintaining protein stability and avoiding aggregation. This is followed by a discussion showing how consistency, planning, and communication are essential elements for a successful biologic drug product technical transfer. The session ends with a presentation of current innovations in injection delivery systems, an update on the demand for large-volume injectors, as well as usability insights on patient delivery methods.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma